Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.17% | 17.81% | 17.21% | -40.87% | -75.48% |
| Total Depreciation and Amortization | 25.09% | 35.87% | 40.47% | 65.69% | 38.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.12% | -55.28% | -41.31% | 66.09% | 138.89% |
| Change in Net Operating Assets | 243.69% | 248.79% | 305.96% | -54.12% | -388.15% |
| Cash from Operations | -17.73% | -5.12% | -6.63% | -10.65% | -27.18% |
| Capital Expenditure | -309.72% | -336.92% | -517.25% | -239.22% | -92.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -98.27% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -311.44% | -339.12% | -522.07% | -862.81% | -1,034.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -103.42% | -145.82% | -243.28% | -177.85% | -308.60% |
| Issuance of Common Stock | -36.73% | -54.31% | 4.78% | 159.92% | 160.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | 100.00% | 100.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 21.44% | 48.07% | 72.76% | -114.76% | -224.16% |
| Cash from Financing | -39.11% | -50.57% | 37.41% | 309.55% | 298.75% |
| Foreign Exchange rate Adjustments | 1.35% | -446.51% | -916.67% | -1,004.76% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.29% | -113.26% | 424.50% | 245.36% | 285.29% |